Upcoming Event

Cleveland Clinic
Department of Biomedical Engineering 
BME Guest Speaker
"Cerebrovascular Care in 2019 - Advances and Challenges"
M. Shazam Hussain, MD
Staff, Cerebrovascular Center
Cleveland Clinic
Friday, November 15, 2019
Hosted by: Vinod Labhasetwar, PhD

Lerner Research Institute (LRI)
The Lerner Research Institute is one of the largest private research facilities in the United States, with hundreds of principal investigators, project scientists, research associates and postdoctoral fellows, with total annual research expenditures exceeding $150 million from federal agencies, non-federal societies and associations and endowment funds. Currently, investigators and their teams are pursuing a range of biomedical questions.
The LRI is home to all laboratory-based, translational and clinical research at Cleveland Clinic. Our mission is to understand the underlying causes of human diseases and to develop new treatments and cures. LRI is an integrated research community consisting of numerous departments and centers.

Biomedical Engineering (BME)
The Department of Biomedical Engineering (BME) is committed to investigation, innovation, and translation of scientific discoveries to enhance patient care. BME Faculty publish widely in peer-reviewed journals, actively pursue patents/licensing, and hold significant research funding from federal/state agencies and industry. Translational research via clinical collaboration is a key aspect of our diverse programs.
BME has a number of science/technology focus areas that correlate with multiple areas of clinical focus. The science/technology areas include Biomechanics, Biomedical Devices, Biomedical Imaging and Computing, BioMEMS/NanoMedicine, Cardiovascular Bioengineering, Matrix Biology, Tissue Engineering and Wound Healing, Neural Control, and Orthopaedic Biology and Bioengineering. The areas of clinical focus are cancer, cardiovascular, dermatology, diabetes, musculoskeletal/orthopaedic, neural, rehabilitation, amd urology/nephrology. BME's depth and breadth of expertise are enhanced by collaborations with many other Cleveland Clinic faculty with joint appointments and a number of scientists from other institutions with adjunct appointments in BME.

Cleveland Clinic
The Cleveland Clinic (formally known as the Cleveland Clinic Foundation) is a multispecialty academic medical center located in Cleveland, Ohio, United States. The Cleveland Clinic is currently regarded as one of the top 4 hospitals in the United States as rated by U.S. News & World Report.[2] The Cleveland Clinic was established in 1921 by four physicians for the purpose of providing patient care, research, and medical education in an ideal medical setting. One of the largest private medical centers in the world, the Cleveland Clinic saw more than 3,200,000 patient visits in 2009, with almost 80,000 hospital admissions. Patients arrive at the Cleveland Clinic from all 50 states and more than 100 nations. The Cleveland Clinic's approximately 2,500 staff physicians and residents represent 120 medical specialties and subspecialties. Cleveland Clinic was ranked number one in America for cardiac care from 1994 to 2010.
Cleveland Clinic is also an Ohio nonprofit corporation which as of December 2010 had 10 regional hospitals in Northeast Ohio, a hospital and family health center in Florida, and a health center in Toronto, Ontario, Canada, a specialty center in Las Vegas, and a hospital in Abu Dhabi opening in 2012.
Cleveland Clinic listing of Medical Devices 
The Orthopaedic & Rheumatologic Institute offers expert diagnosis, treatment and rehabilitation for adults and children with bone, joint or connective tissue disorders. The Institute blends the strengths of Cleveland Clinic's Orthopaedic and Rheumatologic Programs. Our physicians offer comprehensive care at Cleveland Clinic's main campus, Family Health and Surgery Centers, affiliated hospitals, and in Florida. 
Global Cardiovascular Innovation Center (GCIC)
The Global Cardiovascular Innovation Center (GCIC) is a $250 million research and product development consortium established by the Cleveland Clinic to significantly accelerate the commercialization of cardiovascular products. Led by Steve Nissen, M.D, the GCIC is enlisting a team of national leaders in cardiovascular (CV) research, technology development, and investing. The GCIC has been seeded with a $60 million grant from the State of Ohio.

A new GCIC Incubator opened in 2010, a 50,000 square-foot, state-of-the-art facility that will house start-up companies developing innovative cardiovascular and other medical technologies. Click here to learn more about GCIC.